Mobile-first workflow
Designed for accessible use across modern devices and a range of care settings.
Loading AI Cardia
AI CARDIA TECHNOLOGY
AI-assisted ECG insight, designed for clearer clinical decisions.
AI Cardia is developing a mobile-first ECG analysis platform that transforms supported ECG inputs into structured, explainable findings designed to assist healthcare professionals. The system is being developed with human oversight, clinical validation and responsible deployment in mind.
Platform in development
ECG input
AI-assisted analysis
Structured insight
Clinician review
Supported ECG input
Built to process supported ECG signal or image inputs as the platform evolves.
Explainable AI output
Structured findings are designed to show what the system identified and provide relevant context.
Human oversight
AI supports review; qualified healthcare professionals remain responsible for clinical decisions.
Workflow
How the technology works
A clear decision-support pathway from ECG input to professional review.
ECG input
An ECG recording or supported ECG image is securely submitted through the platform.
Input preparation
The submitted input is checked and prepared for analysis through preprocessing and quality-control steps.
AI-assisted pattern analysis
Machine-learning models evaluate supported ECG patterns and produce structured findings.
Explainable summary
The platform presents a clear summary designed to help users understand identified patterns, confidence and relevant context.
Professional review
The output is intended to support, not replace, professional judgment and appropriate clinical follow-up.
Model development
Built around expert-labelled ECG data
Model development relies on curated ECG data, expert-supported labels and iterative evaluation. Data quality, error analysis and responsible validation are treated as essential parts of the development lifecycle.
Data preparation
Expert annotation
Model development
Evaluation and validation
Controlled improvement
Curated ECG datasets and expert labels support supervised learning and evaluation.
Quality review, error analysis and iteration are part of model development.
Product inference during normal use is distinct from controlled model training and validation work.
The platform is not represented as continuously retraining from user health data.
AI that supports, not replaces, clinical judgment
Findings are structured for clarity and intended to provide context rather than an absolute decision. Model outputs should be reviewed within clinical context, and uncertain or poor-quality inputs should be surfaced clearly.
Qualified healthcare professionals remain responsible for diagnosis, treatment and follow-up decisions. A complete medical assessment may require information beyond an ECG.
AI Cardia is being developed as a decision-support platform. It is not a substitute for emergency care, a licensed healthcare professional or a complete medical evaluation. Product capabilities and availability may change as validation and regulatory work progresses.
Capabilities
Product capabilities, carefully qualified
The current public roadmap is framed around focus areas rather than unverified availability claims.
Supported ECG signal and image intake pathways
Structured ECG findings for review workflows
Explainable summaries for clinician-facing decision support
Multilingual explanations and report generation
Secure sharing pathways and clinician-facing review support
Future integration pathways subject to validation and regulatory review
Responsible development for Canadian healthcare
AI Cardia is designed with Canadian privacy requirements in mind, including minimal necessary data collection, informed consent and user control, access controls, auditability, secure product development and planned data-governance processes. Clinical validation and regulatory pathway planning remain subject to legal, clinical and regulatory review.
Designed around real access gaps
The product direction focuses on frontline providers, clinics, rural and underserved care settings, multilingual health communication and scalable digital workflows. The emphasis is responsible Canadian development, clinical partnerships and validation planning.
Roadmap
Technology roadmap
Phases are intentionally qualified and do not imply that regulatory approval is guaranteed.
Decision-support foundation
Foundation under development
- supported ECG input
- structured AI-assisted findings
- explainable output
- clinician-controlled use
Clinical validation and workflow integration
Planned validation pathway
- validation studies
- model evaluation
- quality-management refinement
- pilot workflows
- improved reporting
Expanded regulated capabilities
Subject to authorization
- broader supported patterns
- integration pathways
- regulated diagnostic capabilities where authorized
- scalable Canadian and international deployment
Help shape the next generation of accessible cardiac intelligence.
We are building AI Cardia with clinicians, partners and early users. Join the wait list to follow product development and future validation opportunities.